The iron chaperone poly(rC)-binding protein 1 regulates iron efflux through intestinal ferroportin in mice.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
09 Nov 2023
Historique:
accepted: 13 08 2023
received: 31 03 2023
pmc-release: 09 11 2024
medline: 13 11 2023
pubmed: 25 8 2023
entrez: 25 8 2023
Statut: ppublish

Résumé

Iron is an essential nutrient required by all cells but used primarily for red blood cell production. Because humans have no effective mechanism for ridding the body of excess iron, the absorption of dietary iron must be precisely regulated. The critical site of regulation is the transfer of iron from the absorptive enterocyte to the portal circulation via the sole iron efflux transporter, ferroportin. Here, we report that poly(rC)-binding protein 1 (PCBP1), the major cytosolic iron chaperone, is necessary for the regulation of iron flux through ferroportin in the intestine of mice. Mice lacking PCBP1 in the intestinal epithelium exhibit low levels of enterocyte iron, poor retention of dietary iron in enterocyte ferritin, and excess efflux of iron through ferroportin. Excess iron efflux occurred despite lower levels of ferroportin protein in enterocytes and upregulation of the iron regulatory hormone hepcidin. PCBP1 deletion and the resulting unregulated dietary iron absorption led to poor growth, severe anemia on a low-iron diet, and liver oxidative stress with iron loading on a high-iron diet. Ex vivo culture of PCBP1-depleted enteroids demonstrated no defects in hepcidin-mediated ferroportin turnover. However, measurement of kinetically labile iron pools in enteroids competent or blocked for iron efflux indicated that PCBP1 functioned to bind and retain cytosolic iron and limit its availability for ferroportin-mediated efflux. Thus, PCBP1 coordinates enterocyte iron and reduces the concentration of unchaperoned "free" iron to a low level that is necessary for hepcidin-mediated regulation of ferroportin activity.

Identifiants

pubmed: 37624904
pii: 497634
doi: 10.1182/blood.2023020504
pmc: PMC10656723
doi:

Substances chimiques

Iron E1UOL152H7
Hepcidins 0
metal transporting protein 1 0
Iron, Dietary 0
Cation Transport Proteins 0
Molecular Chaperones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1658-1671

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK089502
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Trends Mol Med. 2021 Feb;27(2):113-122
pubmed: 32958404
Free Radic Biol Med. 2021 Nov 1;175:18-27
pubmed: 34455040
Eur J Nutr. 2012 Oct;51(7):783-9
pubmed: 22009264
Genesis. 2004 Jul;39(3):186-93
pubmed: 15282745
Cell Metab. 2012 Jun 6;15(6):905-17
pubmed: 22682226
Nat Cell Biol. 2012 Mar 04;14(4):401-8
pubmed: 22388892
Cell Metab. 2010 Sep 8;12(3):273-82
pubmed: 20816093
Adv Protein Chem Struct Biol. 2021;123:1-16
pubmed: 33485480
Gastroenterology. 2011 Jun;140(7):2044-55
pubmed: 21419768
Hepatology. 2021 Mar;73(3):1176-1193
pubmed: 32438524
J Clin Invest. 2011 Dec;121(12):4880-8
pubmed: 22045566
Free Radic Biol Med. 2019 Mar;133:112-117
pubmed: 30321701
Biochem J. 2014 Aug 15;462(1):25-37
pubmed: 24854545
Nature. 2000 Feb 17;403(6771):776-81
pubmed: 10693807
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
PLoS One. 2013;8(4):e60534
pubmed: 23565256
ACS Sens. 2020 Sep 25;5(9):2950-2958
pubmed: 32885952
Lancet. 2021 Jan 16;397(10270):233-248
pubmed: 33285139
J Vis Exp. 2011 Aug 05;(54):
pubmed: 21847081
Proc Natl Acad Sci U S A. 2009 Oct 13;106(41):17413-8
pubmed: 19805084
Gastroenterology. 2018 Jan;154(1):168-180.e5
pubmed: 28958857
J Biol Chem. 2013 Jun 14;288(24):17791-802
pubmed: 23640898
Toxicol Appl Pharmacol. 2010 Apr 1;244(1):57-65
pubmed: 20122946
Org Biomol Chem. 2014 Sep 14;12(34):6590-7
pubmed: 24953684
J Biol Chem. 2000 Jun 30;275(26):19906-12
pubmed: 10747949
Cell Metab. 2011 Nov 2;14(5):647-57
pubmed: 22055506
Am J Physiol Gastrointest Liver Physiol. 2015 Oct 15;309(8):G635-47
pubmed: 26294671
Dig Dis Sci. 2016 Mar;61(3):737-46
pubmed: 26520109
Proc Natl Acad Sci U S A. 2021 Jun 22;118(25):
pubmed: 34161287
J Biol Chem. 2016 Aug 12;291(33):17303-18
pubmed: 27302059
Cell Metab. 2015 Nov 3;22(5):777-87
pubmed: 26437604
Free Radic Biol Med. 2019 Mar;133:55-63
pubmed: 30055235
Curr Protoc Mouse Biol. 2013 Dec 19;3(4):217-40
pubmed: 25105065
Blood. 2012 Nov 1;120(18):3829-36
pubmed: 22990014
J Clin Invest. 2017 May 1;127(5):1786-1797
pubmed: 28375153
J Biol Chem. 2015 Sep 25;290(39):23523-7
pubmed: 26296885
Nature. 1997 May 22;387(6631):409-13
pubmed: 9163427
Front Pharmacol. 2014 Jul 28;5:176
pubmed: 25120486
Science. 2008 May 30;320(5880):1207-10
pubmed: 18511687
Cell Metab. 2009 Feb;9(2):152-64
pubmed: 19147412
Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8031-6
pubmed: 24843120
J Biol Chem. 2016 Feb 19;291(8):3759-66
pubmed: 26677228
J Biol Chem. 2017 Aug 4;292(31):12727-12734
pubmed: 28615456
Nature. 1997 Jul 31;388(6641):482-8
pubmed: 9242408
Biochim Biophys Acta Mol Cell Res. 2020 Nov;1867(11):118830
pubmed: 32835748
Science. 2004 Dec 17;306(5704):2090-3
pubmed: 15514116
Methods Mol Biol. 2017;1612:97-105
pubmed: 28634937
Nat Chem Biol. 2019 Sep;15(9):872-881
pubmed: 31406370
Mol Cell. 2000 Feb;5(2):299-309
pubmed: 10882071
Pharmaceuticals (Basel). 2019 Sep 09;12(3):
pubmed: 31505869
J Histochem Cytochem. 1993 Nov;41(11):1599-604
pubmed: 7691930
Nature. 2020 Oct;586(7831):807-811
pubmed: 32814342
Mol Aspects Med. 2020 Oct;75:100866
pubmed: 32564977
Mol Cell Biol. 2015 Nov 02;36(2):304-19
pubmed: 26527618
J Clin Invest. 2019 Jan 2;129(1):336-348
pubmed: 30352047

Auteurs

Yubo Wang (Y)

Genetics and Metabolism Section, Liver Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Olga Protchenko (O)

Genetics and Metabolism Section, Liver Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Kari D Huber (KD)

Genetics and Metabolism Section, Liver Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Minoo Shakoury-Elizeh (M)

Genetics and Metabolism Section, Liver Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Manik C Ghosh (MC)

Section on Human Iron Metabolism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD.

Caroline C Philpott (CC)

Genetics and Metabolism Section, Liver Diseases Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH